SNCAIP

synuclein alpha interacting protein

Explore in graph →CI-GENE-00031612HGNC:11139 ENSG00000064692 NCBI 9627 CIViC Cancer geneApproved

Curated evidence

Clinical evidence (1)

CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.

civicCuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
SNCAIP Tandem duplication1
(diagnostic)	Medulloblastoma, Non-WNT/Non-SHH, Group 4	Diagnostic	B	Supports Positive	3	submitted	EID11193 Analysis of somatic copy number alterations (SCNAs) in 1087 medulloblastoma tumours identified a recurrent tandem duplication of SNCAIP that was restricted to Group 4 medulloblastoma. SNCAIP duplicati… (full text at CIViC) PMID 22832581 · Northcott et al., 2012 · Open in CIViC	civic

Cohorts

Alteration frequency by cohort (12)

Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.

cbioportalObserved12 cohort rows · frequency = affected / profiled, as published by each cohort; cohorts are not pooled. Hover a row badge for its release.

Cohort	Mapped cancer	Alteration	Affected (n)	Profiled (n)	Frequency (%)	Rank in cohort	Source
Desmoplastic Melanoma (Broad Institute, Nat Genet 2015) desm_broad_2015	Desmoplastic Melanoma	Ssm	7	20

Literature

Linked publications (0)

Data not yet available

No publication linked to this gene yet.